In re NuVasive, Inc.
United States Court of Appeals for the Federal Circuit
842 F.3d 1376 (2016)
- Written by Rose VanHofwegen, JD
Facts
NuVasive, Inc. (defendant), held a patent for a spinal implant that used radiopaque markers next to its medial plane to align the implant. Medtronic, Inc. (plaintiff), petitioned the Patent Trial and Appeal Board (PTAB), arguing that combining four existing implant devices with information about radiopaque markers in other applications was obvious. The PTAB found that a person having ordinary skill in the art (PHOSITA) would combine the prior art and additional information to use radiopaque markers, rendering the claim invalid for obviousness. However, in reaching that conclusion, the PTAB credited expert testimony that the markers provided better alignment based on benefits recognized after the priority date of NuVasive’s patent. The ruling did not discuss benefits obtainable solely by combining only prior art references nor what would motivate a PHOSITA to combine them. Medtronic appealed, arguing that the PTAB erred.
Rule of Law
Issue
Holding and Reasoning (Wallach, J.)
What to do next…
Here's why 804,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.